Medfinder
Back to blog

Updated: February 17, 2026

266 people read this article

Alternatives to Qulipta If You Can't Fill Your Prescription

Summarize with AI


Overview

Can't get Qulipta? Explore the best alternatives for migraine prevention in 2026, including Nurtec, Aimovig, Ajovy, and Emgality.

4%Hard to findin stock right now

Is Qulipta in stock near you?

Based on 54 real pharmacy checks · 2 patients helped

Verified 56m ago

Alternatives to Qulipta for Migraine Prevention

If you can't fill your Qulipta prescription — whether it's because of availability issues, insurance problems, cost, or side effects — you still have options. Several other medications work similarly to prevent migraines, and your doctor can help you find the right fit.

In this guide, we'll explain what Qulipta is, how it works, and walk you through four proven alternatives for migraine prevention.

Don't wait on hold.
Check live stock now.

What Is Qulipta?

Qulipta (Atogepant) is a prescription medication made by AbbVie for the preventive treatment of episodic and chronic migraine in adults. It was approved by the FDA in September 2021.

Qulipta is an oral tablet taken once daily, available in 10 mg, 30 mg, and 60 mg strengths. It costs approximately $1,200 to $1,600 per month without insurance, and most plans require prior authorization for coverage.

For more details about Qulipta, including dosage and what to expect, see our guide: What Is Qulipta? Uses, Dosage, and What You Need to Know.

How Does Qulipta Work?

Qulipta belongs to a class of drugs called CGRP receptor antagonists (also known as gepants). CGRP stands for calcitonin gene-related peptide — a protein in your brain that plays a major role in triggering migraines.

During a migraine, CGRP levels spike, causing blood vessels to dilate and nerves to become inflamed, which leads to the throbbing pain, nausea, and sensitivity to light that migraine sufferers know all too well.

Qulipta works by blocking CGRP receptors, preventing CGRP from doing its job. This helps reduce the frequency and severity of migraine attacks before they start. For a deeper dive, read: How Does Qulipta Work? Mechanism of Action Explained.

Alternative 1: Nurtec ODT (Rimegepant)

Nurtec ODT is the closest alternative to Qulipta. Like Qulipta, it's an oral CGRP receptor antagonist (gepant), but with one key difference: Nurtec is approved for both acute migraine treatment and prevention.

For prevention, Nurtec is taken as a 75 mg orally disintegrating tablet every other day. For acute treatment, it's taken as needed when a migraine strikes.

Key facts about Nurtec ODT:

  • Generic name: Rimegepant
  • Manufacturer: Pfizer (Biohaven)
  • How it's taken: Orally disintegrating tablet (dissolves on the tongue)
  • Dosing for prevention: 75 mg every other day
  • Cash price: Approximately $1,000 to $1,200 per month
  • Common side effects: Nausea, stomach pain

Nurtec may be a good option if you want a single medication that can both prevent migraines and treat breakthrough attacks.

40,161+ patients found their medications in stock
40K+
5-star rating

Alternative 2: Aimovig (Erenumab)

Aimovig was the first FDA-approved CGRP treatment for migraine prevention. Unlike Qulipta, Aimovig is a monthly self-injection rather than a daily pill.

Aimovig works by targeting the CGRP receptor directly (similar to Qulipta), but it uses a monoclonal antibody that stays active in your body for about a month.

Key facts about Aimovig:

  • Generic name: Erenumab
  • Manufacturer: Amgen/Novartis
  • How it's taken: Subcutaneous injection once monthly
  • Doses: 70 mg or 140 mg
  • Cash price: Approximately $700 to $800 per month
  • Common side effects: Injection site reactions, constipation, muscle cramps

Aimovig is a good choice if you prefer a once-monthly injection over a daily pill and don't mind self-injecting.

Alternative 3: Ajovy (Fremanezumab)

Ajovy is another injectable CGRP antibody for migraine prevention. What makes Ajovy unique is its flexible dosing schedule — you can choose between monthly or quarterly injections.

Key facts about Ajovy:

  • Generic name: Fremanezumab
  • Manufacturer: Teva Pharmaceuticals
  • How it's taken: Subcutaneous injection
  • Dosing: 225 mg monthly OR 675 mg quarterly (three injections at once)
  • Cash price: Approximately $650 to $750 per month
  • Common side effects: Injection site pain, redness, swelling

Ajovy's quarterly dosing option is ideal if you want to minimize how often you need to think about your migraine prevention treatment.

Skip the calls, skip the stress.
50K+
Medications
Found
99%
Success
Rate
6+
Hours saved
on average

Alternative 4: Emgality (Galcanezumab)

Emgality is a monthly injectable CGRP antibody that targets the CGRP molecule itself (rather than the receptor). It's also the only CGRP treatment approved for both migraine prevention and episodic cluster headache.

Key facts about Emgality:

  • Generic name: Galcanezumab
  • Manufacturer: Eli Lilly
  • How it's taken: Subcutaneous injection once monthly
  • Dosing: 120 mg monthly after a 240 mg loading dose
  • Cash price: Approximately $650 to $750 per month
  • Common side effects: Injection site reactions, dizziness, constipation

Emgality may be worth considering if you also experience cluster headaches in addition to migraines.

How to Choose the Right Alternative

The best alternative depends on your individual situation. Here are some questions to discuss with your doctor:

  • Do you prefer pills or injections? Nurtec ODT is the only oral alternative. Aimovig, Ajovy, and Emgality are all injections.
  • Do you also need acute migraine treatment? Nurtec ODT can treat and prevent migraines. The others are prevention-only.
  • How often do you want to take medication? Ajovy offers quarterly dosing. Aimovig and Emgality are monthly. Nurtec is every other day.
  • What does your insurance cover? Coverage varies significantly. Your insurance may prefer one CGRP treatment over another.
  • Do you have constipation issues? Qulipta and Aimovig are more likely to cause constipation than Ajovy or Emgality.

Final Thoughts

Not being able to fill your Qulipta prescription is frustrating, but the good news is that migraine prevention has more options than ever. Whether you try another oral gepant like Nurtec ODT or switch to an injectable CGRP antibody like Aimovig, Ajovy, or Emgality, your doctor can help you find an effective alternative.

Before switching, try using Medfinder to check if Qulipta is available at other pharmacies near you. You can also read our guide on how to find Qulipta in stock for more tips.

Related articles:

Real-time availability

Is Qulipta in stock near you?

In shortage
4%Hard to findin stock right now

Verified 56m ago

Based on 54 real pharmacy checks · 2 patients helped

Qulipta is in a shortage right now — Medfinder calls pharmacies near you to track down the ones that have it.

As of August 19, 2026, 8:00 PM ET, Qulipta is currently experiencing a shortage. Across 54 pharmacy checks Medfinder placed in the last 30 days, Qulipta was confirmed in stock 4% of the time.

Pharmacy checks
54
FDA status
Not listed
Updated
56m ago

Qulipta is not on the FDA's active shortage list. Medfinder's own pharmacy calls put real-time availability at 4% across 54 checks in the last 30 days. Availability varies by metro, with the most pharmacy activity recorded around Brick Township, NJ. These numbers are recomputed continuously from live pharmacy calls, so this page reflects current conditions rather than a static estimate.

Qulipta availability questions

Is Qulipta in stock right now?

As of August 19, 2026, 8:00 PM ET, Qulipta was confirmed in stock at 4% of 54 pharmacies Medfinder checked in the last 30 days. Availability changes daily, so we re-check in real time when you search.

How does Medfinder help me find Qulipta?

Medfinder calls pharmacies in your area to verify whether Qulipta and your specific dose are in stock, then sends you the pharmacy name, address, and phone number.

Need Qulipta? We'll find the pharmacy that has it.

Sources: FDA Drug Shortages + Medfinder pharmacy data · Methodology · Full Qulipta data

Frequently Asked Questions

Nurtec ODT (Rimegepant) is the closest alternative. Like Qulipta, it's an oral CGRP receptor antagonist taken by mouth. Nurtec is taken every other day for prevention and is also approved for acute migraine treatment. It costs approximately $1,000 to $1,200 per month without insurance.

Yes. Aimovig (Erenumab), Ajovy (Fremanezumab), and Emgality (Galcanezumab) are all injectable CGRP treatments for migraine prevention. Talk to your doctor about switching — there's typically no washout period needed when changing between CGRP medications.

Yes. Older generic medications like Topiramate, Propranolol, Amitriptyline, and Valproate are used for migraine prevention and cost much less (often under $30 per month). However, they work differently than CGRP treatments and may have different side effects. Talk to your doctor about whether a generic preventive is appropriate for you.

As of early 2026, there are no generic versions of Qulipta or any other CGRP medication (Nurtec, Aimovig, Ajovy, Emgality). All are still brand-name only. Generic competition for Qulipta may be possible after patent challenges, but no generic Atogepant has been approved yet.

How do I find Qulipta in stock near me?
Medfinder checks real pharmacy inventory and finds the pharmacies that have it.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Qulipta also looked for:

40,161 have already found their meds with Medfinder.

Start your search today.

40K+
5-star ratingTrusted by 40,161 Happy PatientsRead our reviews on Trustpilot →
      What med are you looking for?
⊙  Find Your Meds

Your information is private and never shared.

99% success rate
Fast turnaround time
Never call another pharmacy

Find Qulipta in stock